Kawas Leen
Reporting Owner SEC Filing List
CIK: 0001822491
| Form | Filer | Subject Company | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Kawas Leen | Broadridge Financial Solutions, Inc. /fa | 11/02/2023 | |
| 4 | Statement of changes in beneficial owner... | Eiger Biopharmaceuticals, Inc. | Broadridge Financial Solutions, Inc. /fa | 11/02/2023 | |
| 3 | Initial statement of beneficial ownershi... | Kawas Leen | Broadridge Financial Solutions, Inc. /fa | 10/30/2023 | |
| 3 | Initial statement of beneficial ownershi... | Eiger Biopharmaceuticals, Inc. | Broadridge Financial Solutions, Inc. /fa | 10/30/2023 | |
| 4 | Statement of changes in beneficial owner... | Athira Pharma, Inc. | Donnelley Financial Solutions File16 /fa | 02/22/2021 | |
| 4 | Statement of changes in beneficial owner... | Kawas Leen | Donnelley Financial Solutions File16 /fa | 02/22/2021 | |
| 3 | Initial statement of beneficial ownershi... | Athira Pharma, Inc. | Donnelley Financial Solutions File16 /fa | 09/17/2020 | |
| 3 | Initial statement of beneficial ownershi... | Kawas Leen | Donnelley Financial Solutions File16 /fa | 09/17/2020 |
Kawas Leen 's Ownership Transactions
| Issuer | Filing Date | Transaction Date | Transaction Type | Shares | Price | Total Amt | Shares Owned |
|---|
